Roles of TGF-β1 and apoptosis in the progression of glomerulosclerosis in human IgA nephropathy

Clinical Nephrology

Volumn 65, Issue 6, 2006, Pages 385-392

  Chihara, Y ^a   Ono, H ^b   Ishimitsu, T ^b   Ono, Y ^b   Ishikawa, K ^a   Rakugi, H ^a   Ogihara, T ^a   Matsuoka, H ^b  

^a OSAKA UNIVERSITY GRADUATE SCHOOL OF MEDICINE   (Japan)

^b DOKKYO MEDICAL UNIVERSITY   (Japan)

Author keywords

Apoptosis; Glomerulosclerosis; IgA nephropathy; TGF 1

Indexed keywords

ALBUMIN; CASPASE 3; CREATININE; DNA FRAGMENT; IMMUNOGLOBULIN A; MESSENGER RNA; NITROGEN; POTASSIUM; SODIUM; TRANSFORMING GROWTH FACTOR BETA1; UREA; URIC ACID;

ADULT; ALBUMIN BLOOD LEVEL; APOPTOSIS; ARTICLE; CLINICAL ARTICLE; COMPUTER AIDED DESIGN; CONTROLLED STUDY; CREATININE BLOOD LEVEL; DISEASE COURSE; DISEASE SEVERITY; FEMALE; FIBROSING ALVEOLITIS; GLOMERULOSCLEROSIS; HUMAN; HUMAN TISSUE; IMMUNOGLOBULIN A NEPHROPATHY; IMMUNOGLOBULIN BLOOD LEVEL; KIDNEY BIOPSY; KIDNEY CELL; LYMPHOCYTIC INFILTRATION; MALE; MORPHOMETRICS; NICK END LABELING; POTASSIUM BLOOD LEVEL; PROTEIN BLOOD LEVEL; PROTEIN EXPRESSION; PROTEINURIA; REAL TIME POLYMERASE CHAIN REACTION; SODIUM BLOOD LEVEL; UREA NITROGEN BLOOD LEVEL; CLASSIFICATION; COMPARATIVE STUDY; FOCAL GLOMERULOSCLEROSIS; IMMUNOHISTOCHEMISTRY; METABOLISM; METHODOLOGY; MIDDLE AGED; PATHOLOGY; PHYSIOLOGY; URINE;

ADULT; APOPTOSIS; CASPASE 3; CREATININE; DISEASE PROGRESSION; FEMALE; GLOMERULONEPHRITIS, IGA; GLOMERULOSCLEROSIS, FOCAL SEGMENTAL; HUMANS; IMMUNOHISTOCHEMISTRY; IN SITU NICK-END LABELING; MALE; MIDDLE AGED; TRANSFORMING GROWTH FACTOR BETA1;

EID: 33744965583     PISSN: 03010430     EISSN: None     Source Type: Journal    
DOI: 10.5414/CNP65385     Document Type: Article

References (24)

1. Alamartine E, Sabatier JC, Guerin C, Berliet JM, Berthoux F. Prognostic factors in mesangial IgA glomerulonephritis: an extensive study with univariate and multivariate analyses. Am J Kidney Dis. 1991; 18: 12-19.
2. Amore A, Cirina P, Conti G, Brusa P, Peruzzi L, Coppo R. Glycosylation of circulating IgA in patients with IgA nephropathy modulates proliferation and apoptosis of mesangial cells. J Am Soc Nephrol. 2001; 12: 1862-1871.
3. Blobe GC, Schiemann WP, Lodish HF. Role of transforming growth factorβ in human disease. N Engl J Med. 2000; 342: 1350-1358.
4. Border WA, Noble NA, Yamamoto T, Harper JR, Yamaguchi Y, Pierschbacher MD, Ruoslahti E. Natural inhibitor of transforming growth factor-β protects against scarring in experimental kidney disease. Nature. 1992; 360: 361-364.
5. Bottinger, EP, Bitzer M. TGF-beta signaling in renal disease. J Am Soc Nephrol. 2002; 13: 2600-2610.
6. Chacko B, John GT, Neelakantan N, Korula A, Balakrishnan N, Kirubakaran MG, Jacob CK. Presentation, prognosis and outcome of IgA nephropathy in Indian adults. Nephrology. 2005; 10: 496-503.
7. D'Amico G, Minetti L, Ponticelli C, Fellin G, Ferrario F, di Belgioioso GB, Imbasciati E, Ragni A, Bertoli S, Fogazzi G, Duca G. Prognostic indicators in idiopathic IgA mesangial nephropathy. Q J Med. 1986; 59: 363-378.
8. D'Amico G. The commonest glomerulonephritis in the world: IgA nephropathy. Q J Med. 1987; 64: 709-727.
9. D'Amico G. Natural history of idiopathic IgA nephropathy and factors predictive of disease outcome. Semin Nephrol. 2004; 24: 179-196.
10. Gibson UEM, Heid CA, Williams PM. A novel method for real-time quantitative RT-PCR. Genome Res. 1996; 6: 995-1001.
11. Jang CW, Chen CH, Chen CC, Chen JY, Su YH, Chen RH. TGF-beta induces apoptosis through Smad-mediated expression of DAP-kinase. Nat Cell Biol. 2002; 4: 51-58.
12. Julian BA, Waldo FB, Rifai A, Mestecky J. IgA nephropathy, the most common glomerulonephritis worldwide. A neglected disease in the United States? Am J Med. 1988; 84: 129-132.
13. Kusano H, Muso E, Ono T, Nogaki F, Nomura K, Takeda T, Miyawaki S, Matsumori A, Yoshida H, Sasayama S. Heminephrectomy causes the progression of glomerulosclerosis and apoptosis in high IgA strain ddY mice. Nephron. 2002; 92: 389-398.
14. Makino H, Kashihara N, Sugiyama H, Kanao K, Sekikawa T, Okamoto K, Maeshima Y, Ota Z, Nagai R. Phenotypic modulation of the mesangium reflected by contractile proteins in diabetes. Diabetes. 1996; 45: 488-495.
15. Okado T, Terada Y, Tanaka H, Inoshita S, Nakao A, Sasaki S. Smad7 mediates transforming growth factor-beta-induced apoptosis in mesangial cells. Kidney Int. 2002; 62: 1178-1186.
16. Ono H, Ono Y, Takanohashi A, Matsuoka H, Frohlich ED. Apoptosis and glomerular injury after prolonged nitric oxide synthase inhibition in spontaneously hypertensive rats. Hypertension. 2001; 38: 1300-1306.
17. 1 inhibition in spontaneously hypertensive rats. J Hypertens. 2004; 22: 1389-1395.
18. Ribeiro A, Bronk SF, Roberts PJ, Urrutia R, Gores GJ. The transforming growth factor beta(1)-inducible transcription factor TIEG1, mediates apoptosis through oxidative stress. Hepatology. 1999; 30: 1490-1497.
19. Ruef C, Budde K, Lacy J, Northemann W, Baumann M, Sterzel RB, Coleman DL. Interleukin 6 is an autocrine growth factor for mesangial cells. Kidney Int. 1990; 38: 249-257.
20. Shimizu A, Kitamura H, Masuda Y, Ishizaki M, Sugisaki Y, Yamanaka N. Apoptosis in the repair process of experimental proliferative glomerulonephritis. Kidney Int. 1995; 47: 114-121.
21. Sugiyama H, Kashihara N, Makino H, Yamasaki Y, Ota A. Apoptosis in glomerular sclerosis. Kidney Int. 1996; 49: 103-111.
22. 2 and epidermal growth factor in IgA nephropathy. Scand J Urol Nephrol. 1999; 33: 243-247.
23. Tashiro K, Kodera S, Takahashi Y, Horikoshi S, Shirato I, Tomino Y. Detection of apoptotic cells in glomeruli of patients with IgA nephropathy. Nephron. 1998; 79: 21-27.
24. 1 mRNA as a marker of glomerulosclerosis applicaton in renal biopsies. Nephron. 1997; 77: 290-297.